Last reviewed · How we verify
1L Klean prep® and 2 sachets Picoprep®
1L Klean prep® and 2 sachets Picoprep® is a marketed bowel preparation regimen developed by Queen Elizabeth Hospital, Hong Kong. The key composition patent expires in 2028, providing a strong barrier to generic competition until then. The primary risk is the lack of revenue data, which limits the ability to assess market performance and financial impact.
At a glance
| Generic name | 1L Klean prep® and 2 sachets Picoprep® |
|---|---|
| Sponsor | Queen Elizabeth Hospital, Hong Kong |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: